2019
DOI: 10.1186/s12920-019-0528-1
|View full text |Cite
|
Sign up to set email alerts
|

Next-generation sequencing for identifying a novel/de novo pathogenic variant in a Mexican patient with cystic fibrosis: a case report

Abstract: Background Mexico is among the countries showing the highest heterogeneity of CFTR variants. However, no de novo variants have previously been reported in Mexican patients with cystic fibrosis (CF). Case presentation Here, we report the first case of a novel/de novo variant in a Mexican patient with CF. Our patient was an 8-year-old male who had exhibited the clinical onset of CF at one month of age, with steatorrhea, malabsorption, poor weigh… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(5 citation statements)
references
References 30 publications
0
4
0
Order By: Relevance
“…Variants occurring de novo in the CFTR gene are extremely rare, with approximately 10 cases of de novo CFTR variants published to date. 58 There was an interesting finding that two de novo variants (c.960dupA[p.Ser321IlefsX43] and c.2491-2A>G) were identified among Chinese, which were confirmed after paternity test as well as CFTR gene screening for the biological parents. Furthermore, both de novo variants were found in Beijing Children’s Hospital.…”
Section: Discussionmentioning
confidence: 99%
“…Variants occurring de novo in the CFTR gene are extremely rare, with approximately 10 cases of de novo CFTR variants published to date. 58 There was an interesting finding that two de novo variants (c.960dupA[p.Ser321IlefsX43] and c.2491-2A>G) were identified among Chinese, which were confirmed after paternity test as well as CFTR gene screening for the biological parents. Furthermore, both de novo variants were found in Beijing Children’s Hospital.…”
Section: Discussionmentioning
confidence: 99%
“…As the molecular diagnosis of the disease in Mexico is very complex, and because Mexico is a middle-income country, we applied a combination of methodologies. As a first step, we screened for the five most frequent mutations by PSM [ 10 , 12 ], a low-cost tool that allowed us to identify more than 40% of the alleles. This step was followed by PV screening using NGS and MLPA.…”
Section: Discussionmentioning
confidence: 99%
“…The molecular screening was performed in two steps. First, we screened the five most frequent PVs in the Mexican population [p.(Ile507del), p.(Phe508del), p.(Gly542*), p.(Ser549Asn), and p.(Asn1303Lys)] using PCR-mediated site-directed mutagenesis (PSM) as described previously [ 10 , 12 ]. Second, in those patients with at least one unidentified allele, CFTR sequencing was performed using next-generation sequencing (NGS).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“… 10 As a result, only a few reports of de novo mutations in the CFTR gene have been published, with only 10 identified so far. 11 17 …”
Section: Introductionmentioning
confidence: 99%